Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Banyu developing new anticancer agent

June 4, 1997

RCT issued U.S. patent for azonafide compounds

June 3, 1997

Receptagen receives notice of allowance of U.S. patent for "growth blocker" technology

June 3, 1997

Alpha Therapeutic and Techniclone report milestone in LYM-1 clinical development

June 3, 1997

Schering-Plough's Fareston approved by the FDA

June 3, 1997

Nippon Kayaku discovers new antitumor agent

June 3, 1997

CAAX-based protein farnesyltransferase inhibitors from Merck & Co.

June 3, 1997

Ludwig Institute describes new tumor rejection antigens

June 3, 1997

Identification of novel polyamine compounds with anticancer activity

June 3, 1997

Lilly and Megabios enter gene-based therapeutics collaboration

June 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....